• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.

Andrew Jacobs
Author: Andrew Jacobs

Written by

Andrew Jacobs

in

Clinical Trials, Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, LSD (Lysergic Acid Diethylamide), Lykos Therapeutics, Mental Health and Disorders, Post-Traumatic Stress Disorder, Psilocybin Mushrooms, Psychedelic and Hallucinogenic Drugs, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Therapy and Rehabilitation, Veterans
←Stellantis Will Lay Off Up to 2,450 at Michigan Truck Plant
Los Juegos Olímpicos en 9 momentos sexis→

More posts

  • WATCH: Gen Z turn to ‘grandma hobbies’ to fight screen time

  • Oil Falls and Stocks Rise After a Day of Drastic Swings

  • Gas Prices Hit $3.54 a Gallon, Up 19% Since Attacks on Iran

  • F.A.A. Briefly Halts JetBlue Departures After System Outage

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube